IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics, software, and water testing solutions with a market cap of $52.5 billion. The company’s focus on innovation and digital solutions has led to a 26.4% increase in shares over the past three months.

Shares of IDXX have rallied 36.5% over the past 52 weeks, outperforming the Health Care Select Sector SPDR Fund (XLV). The company’s strong Q2 2025 earnings release led to a 27.5% increase in shares on August 4, with revenue up 10.6% year-over-year.

Despite its outperformance, analysts have a “Moderate Buy” rating on IDXX, with a mean price target of $722.60, a 10.2% premium to current levels. The company’s robust bottom-line performance and raised fiscal 2025 EPS outlook have bolstered investor confidence.

Read more at Yahoo Finance: Is IDXX Outperforming the Healthcare Sector?